BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 22143855)

  • 21. Medicare prescription drug coverage (part D): challenges and opportunities.
    Witten B
    Nephrol News Issues; 2006 Aug; 20(9):14-6, 18. PubMed ID: 16916055
    [No Abstract]   [Full Text] [Related]  

  • 22. A medical economic fairy tale: Jack, the magic beans, Medicare and the US FDA.
    Nusbaum NJ
    Drugs Aging; 2006; 23(6):447-50. PubMed ID: 16872229
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Drug card setback highlights need for cost relief.
    Gundling RL
    Healthc Financ Manage; 2003 Apr; 57(4):50-4. PubMed ID: 12735187
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Access to expensive drugs in the NHS: myths and realities for cancer patients.
    Mehta AB; Low E
    Int J Clin Pract; 2007 Dec; 61(12):2126-9. PubMed ID: 17997811
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Unexpected "donut hole" raises concerns that patients will fail to fill needed prescriptions.
    Howard-Ruben J
    ONS News; 2006 Dec; 21(12):10-1. PubMed ID: 17193936
    [No Abstract]   [Full Text] [Related]  

  • 26. Medicine reimbursement recommendations in Canada, Australia, and Scotland.
    Lexchin J; Mintzes B
    Am J Manag Care; 2008 Sep; 14(9):581-8. PubMed ID: 18778173
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Legal boundaries of negative and positive lists].
    Arndt M
    Z Arztl Fortbild Qualitatssich; 1997 Nov; 91(7):630-2. PubMed ID: 9527457
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Reforming patient assistance programs: perfect world meets real world.
    Weinberg M
    Health Aff (Millwood); 2009; 28(3):839-42. PubMed ID: 19414895
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Author reply: exploring the implications of a fixed budget for new medicines: a study of reimbursement of new medicines in Australia and New Zealand.
    Taylor CB; Wonder M
    Aust Health Rev; 2016 Feb; 40(1):120. PubMed ID: 26254890
    [No Abstract]   [Full Text] [Related]  

  • 30. Comparing the reimbursement of new medicines between Australia and New Zealand.
    Ragupathy R; Babar ZU
    Aust Health Rev; 2016 Feb; 40(1):118-119. PubMed ID: 26189014
    [No Abstract]   [Full Text] [Related]  

  • 31. Prescription drugs: elderly enrollee reports of financial access, receipt of free samples, and discussion of generic equivalents related to type of coverage.
    Taira DA; Iwane KA; Chung RS
    Am J Manag Care; 2003 Apr; 9(4):305-12. PubMed ID: 12703674
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Health and Wellness Trust Fund Commission funds prescription drug programs in North Carolina.
    Perdue BE
    N C Med J; 2003; 64(6):283-4. PubMed ID: 14983618
    [No Abstract]   [Full Text] [Related]  

  • 33. Dialogue. Prescription for problems? Capitating mental health drugs--the great debate.
    Docherty JP; Browne RA; Farmer M
    Behav Healthc Tomorrow; 1998 Oct; 7(5):32-8. PubMed ID: 10185199
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Economic aspects of the new Spanish laws on pharmaceutical preparations.
    Antoñanzas F; Oliva J; Pinillos M; Juàrez C
    Eur J Health Econ; 2007 Sep; 8(3):297-300. PubMed ID: 17401592
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Patient Access to Medicines for Rare Diseases in European Countries.
    Detiček A; Locatelli I; Kos M
    Value Health; 2018 May; 21(5):553-560. PubMed ID: 29753352
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Racial disparities in prescription drug use among dually eligible beneficiaries.
    Schore J; Brown R; Lavin B
    Health Care Financ Rev; 2003; 25(2):77-90. PubMed ID: 15124379
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prescription drugs are the biggest bargain in health care, and all Americans should have access to them.
    Holmer AF
    Md Med; 2003; 4(2):48-9. PubMed ID: 12847830
    [No Abstract]   [Full Text] [Related]  

  • 38. Pharmaceuticals Licensing and Reimbursement in the European Union, United States, and Japan.
    Oye KA; Eichler HG; Hoos A; Mori Y; Mullin TM; Pearson M
    Clin Pharmacol Ther; 2016 Dec; 100(6):626-632. PubMed ID: 27618128
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Medication access and continuity under Medicare Part D.
    Pollack DA
    Am J Psychiatry; 2007 May; 164(5):700-1. PubMed ID: 17475724
    [No Abstract]   [Full Text] [Related]  

  • 40. Access to medicines report cards.
    Mullard A
    Nat Rev Drug Discov; 2016 Nov; 15(12):811. PubMed ID: 27895336
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.